Ulrich Martin Fuhs - Apr 3, 2024 Form 3 Insider Report for ALPINE IMMUNE SCIENCES, INC. (ALPN)

Role
Chief Accounting Officer
Signature
/s/ James Paul Rickey
Stock symbol
ALPN
Transactions as of
Apr 3, 2024
Transactions value $
$0
Form type
3
Date filed
4/5/2024, 07:11 PM
Next filing
May 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ALPN Common Stock 7.3K Apr 3, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALPN Stock Option (Right to buy) Apr 3, 2024 Common Stock 75K $12.07 Direct F2
holding ALPN Stock Option (Right to buy) Apr 3, 2024 Common Stock 28.7K $7.91 Direct F3
holding ALPN Stock Option (Right to buy) Apr 3, 2024 Common Stock 14.6K $35.89 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units, or RSUs, each of which represents a contingent right to receive one share of the issuer's common stock. 1/4th of the RSUs will vest on January 1, 2025, and the remainder will vest in twelve (12) equal quarterly installments on April 1, 2025, July 1, 2025, October 1, 2025 and on January 1, April 1, July 1, and October 1 of each subsequent year until all RSUs are vested on January 1, 2028, subject to the reporting person continuing to be a service provider through each date.
F2 1/4th of the shares subject to the option vested on November 30, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the reporting person continuing to be a service provider through each date.
F3 1/4th of the shares subject to the option vested on March 22, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the reporting person continuing to be a service provider through each date.
F4 1/4th of the shares subject to the option will vest on March 14, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the reporting person continuing to be a service provider through each date.

Remarks:

Ex.24 Power of Attorney